1995
DOI: 10.1016/0272-7358(95)00048-8
|View full text |Cite
|
Sign up to set email alerts
|

A meta-analysis of treatment outcome for panic disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

17
290
0
44

Year Published

1998
1998
2008
2008

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 473 publications
(351 citation statements)
references
References 53 publications
17
290
0
44
Order By: Relevance
“…Effect sizes (ES) between the treatment conditions and the wait-list calculated on the post-treatment composite scores (Gould et al, 1995.) The treatments were all more effective than the wait-list, with large effect sizes overall, …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Effect sizes (ES) between the treatment conditions and the wait-list calculated on the post-treatment composite scores (Gould et al, 1995.) The treatments were all more effective than the wait-list, with large effect sizes overall, …”
Section: Resultsmentioning
confidence: 99%
“…A coding system was used in which one category was designated a reference category (Tabachnick & Fidell 1996). Sample size was based on a mean effect size for CBT for panic disorder of 0.68 (Gould, et al, 1995), and calculated based on 80% power, two-tailed α = 0.05, and a drop-out rate of 10-15%.…”
Section: Discussionmentioning
confidence: 99%
“…Six health economic studies of CBT for anxiety disorders were identified (10,11,14,33,43,45). A total of 232 primary care patients with PD were randomized to a combined CBT and pharmacology condition or to TAU (33).…”
Section: Abbreviations Used In This Articlementioning
confidence: 99%
“…A metaanalysis of PD outcomes compared direct costs of 15 CBT sessions with boosters to medication (10). At 1 year, the cheapest intervention was imipramine, closely followed by group CBT and individual CBT.…”
Section: Abbreviations Used In This Articlementioning
confidence: 99%
“…9 Numerous studies have confirmed the effectiveness of drug therapy for PD. [10][11][12] Among the pharmacological options used in the treatment of PD are selective serotonin reuptake inhibitors (SSRI), tricyclic antidepressants (TAD), monoamine oxidase inhibitors (MAOI), serotonin and noradrenaline reuptake inhibitors (SNRI), and benzodiazepines. 13 However, many patients, although being under drug therapy, remain symptomatic and have recurrence of symptoms.…”
Section: Introductionmentioning
confidence: 99%